LL-37 for Labs: Why MICs <10 μg/mL Mislead and How to Fix Assays
Lab primer on LL-37: structure–function mechanisms, why MICs often read <10 μg/mL but falter in physiological salt, common assay pitfalls, CoA checks, and…
Lab Researchers: Pick Bacteriostatic or Sterile Water by Label and COA
Lab guide for researchers: choose bacteriostatic or sterile water, know benzyl alcohol risks, the 28 day reuse window, and how to read labels and COAs.
6 Step SOP for Labs: Match Sequence Features to Peptide Solvents
Lab ready 6 step SOP maps net charge and hydrophobicity to the mildest effective peptide solvents. Includes CoA checks and stepwise reconstitution tips.
Peptide Pricing Guide for Labs: Use PAC mg and a 5 Step Verification
Use this procurement-ready peptide pricing guide to calculate PAC mg, run a five step COA verification checklist, and avoid $300–$500 audit fees and…
Lot Match First: Read Peptide Endotoxin COAs for Researchers
Verify peptide endotoxin COAs: confirm lot number, testing lab, method and units (EU/mL or EU/mg), plus spike recovery data so you can trust each batch.
2026 Review: TB-500 Research for Labs Flags Ac-LKKTE Metabolite
Research-first summary for labs separating TB-500 fragment evidence from full-length Tb4. Highlights the Ac-LKKTE metabolite finding and outlines assay,…
Researchers: Follistatin 344, AAV 2–3× Primate Gains, Not Peptide Vials
For researchers: why AAV and engineered follistatin data don’t translate to peptide vials, and which PK/PD, COA and ocular/reproductive checks labs must run.
QC Labs: When Assay Is Over 100% but Purity Under 98%, Read the CoA
QC labs and analytical chemists: learn to read assay and purity on a CoA, why assay can exceed 100% while purity cannot, and how to troubleshoot…
Lab Buyers: Why 99% Peptide Purity Can Hide 10–40% Less Peptide
A procurement guide for lab buyers: learn why 99% HPLC purity can overstate peptide mass, how to read lot-specific COAs, and what documentation to demand…
IGF-1 Rises in 4–6 Weeks: Sermorelin Research for Clinicians
Evidence-first review for clinicians and investigators: trial summaries, FDA history, safety, IGF-1 timing (4–6 weeks), and batch COA checks for…